Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan

被引：0
|
作者：
Su, Wei-Juin
Huang, Shiang-Fen
Chen, Ming-Han
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.PA2682
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2682
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large US healthcare system
    Hwang, Yeon Mi
    Wei, Qi
    Piekos, Samantha N.
    Vemuri, Bhargav
    Molani, Sevda
    Mease, Philip
    Hood, Leroy
    Hadlock, Jennifer
    ECLINICALMEDICINE, 2024, 68
  • [42] Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study
    Goessens, Laurent
    Colombel, Jean-Frederic
    Outtier, An
    Ferrante, Marc
    Sabino, Joao
    Judge, Ciaran
    Saeidi, Reza
    Rabbitt, Louise
    Armuzzi, Alessandro
    Domenech, Eugeni
    Michalopoulos, George
    Cremer, Anneline
    Javier Garcia-Alonso, Francisco
    Molnar, Tamas
    Karmiris, Konstantinos
    Gecse, Krisztina
    Van Oostrom, Joep
    Loewenberg, Mark
    Farkas, Klaudia
    Atreya, Raja
    Ribaldone, Davide Giuseppe
    Selinger, Christian
    Hoentjen, Frank
    Bihin, Benoit
    Sebastian, Shaji
    Rahier, Jean-Francois
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (10) : 1136 - 1147
  • [43] Comparison of two interferon-γ release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases
    Kleinert, S.
    Kurzai, O.
    Elias, J.
    Marten, K.
    Engelke, C.
    Feuchtenberger, M.
    Sandstede, J.
    Frosch, M.
    Tony, H-P
    Kneitz, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 782 - 784
  • [44] Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
    Wieske, Luuk
    van Dam, Koos P. J.
    Steenhuis, Maurice
    Stalman, Eileen W.
    Kummer, Laura Y. L.
    van Kempen, Zoe L. E.
    Killestein, Joep
    Volkers, Adriaan G.
    Tas, Sander W.
    Boekel, Laura
    Wolbink, Gerrit J.
    van der Kooi, Anneke J.
    Raaphorst, Joost
    Lowenberg, Mark
    Takkenberg, R. Bart
    D'Haens, Geert R. A. M.
    Spuls, Phyllis, I
    Bekkenk, Marcel W.
    Musters, Annelie H.
    Post, Nicoline F.
    Bosma, Angela L.
    Hilhorst, Marc L.
    Vegting, Yosta
    Bemelman, Frederike J.
    Voskuyl, Alexandre E.
    Broens, Bo
    Sanchez, Agner Parra
    van Els, Cecile A. C. M.
    de Wit, Jelle
    Rutgers, Abraham
    de Leeuw, Karina
    Horvath, Barbara
    Verschuuren, Jan J. G. M.
    Ruiter, Annabel M.
    van Ouwerkerk, Lotte
    van der Woude, Diane
    Allaart, Renee C. F.
    Teng, Y. K. Onno
    van Paassen, Pieter
    Busch, Matthias H.
    Jallah, Papay B. P.
    Brusse, Esther
    van Doorn, Pieter A.
    Baars, Adaja E.
    Hijnen, Dirk Jan
    Schreurs, Corine R. G.
    van der Pol, W. Ludo
    Goedee, H. Stephan
    Keijzer, Sofie
    Keijser, Jim B. D.
    LANCET RHEUMATOLOGY, 2022, 4 (05): : E338 - E350
  • [45] Screening for latent tuberculosis infection prior to biologic therapy in patients with chronic immune-mediated inflammatory diseases (IMID): Interferon-gamma release assay (IGRA) versus tuberculin skin test (TST)
    Sellami, Meriem
    Fazaa, Alia
    Cheikh, Myriam
    Miladi, Saousen
    Ouenniche, Kmar
    Ennaifer, Rym
    Ben Abdelghani, Kaouther
    Laatar, Ahmed
    EGYPTIAN RHEUMATOLOGIST, 2019, 41 (03): : 225 - 230
  • [46] Support Programme for Patients Receiving Imraldi or Benepali Therapy for Immune-Mediated Inflammatory Disorders: 12-Month Persistence
    Clark, Andrew
    Shering, Teresa
    Addison, Janet
    RHEUMATOLOGY, 2024, 63
  • [47] Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort
    Marin-Jimenez, Ignacio
    Gisbert, Javier P.
    Perez-Calle, Jose L.
    Garcia-Sanchez, Valle
    Tabernero, Susana
    Garcia-Vicuna, Rosario
    Romero, Cristina
    Julia, Berta
    Vanaclocha, Francisco
    Cea-Calvo, Luis
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2015, 38 (10): : 569 - 574
  • [48] SUPPORT PROGRAMME FOR PATIENTS RECEIVING IMRALDI OR BENEPALI THERAPY FOR IMMUNE-MEDIATED INFLAMMATORY DISORDERS: 12-MONTH PERSISTENCE
    Clark, Andrew
    Shering, Teresa
    Addison, Janet
    RHEUMATOLOGY, 2024, 63
  • [49] Adherence to infliximab treatment in patients with immune-mediated inflammatory diseases from a referral center in Brazil: a cohort study
    Lauton, Priscila Moreira
    Pereira, Fernanda Silva
    Oliveira, Livia Brito
    Brauer, Alline Mikaelle Nunes Wildemberg
    de Araujo Costa Beisl Noblat, Lucia
    Santana, Genoile Oliveira
    Santos, Pablo Moura
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [50] IMMUNE RESPONSE AFTER COVID-19 VACCINATION DURING MAINTANACE THERAPY IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: AN OBSERVATIONAL COHORT STUDY
    Dayam, R. M.
    Law, Jaclyn C.
    Goetgebuer, Rogier
    Chao, Gary
    Stempak, Joanne M.
    Pereira, Daniel
    Acheampong, Lily
    Rizwan, Saima
    Milgrom, Raquel
    Rymaszewski, Klaudia
    Ganatra, Darshini
    Finkelstein, Naomi
    Croitoru, David
    Lau, Irene
    Law, Ryan
    Girard, Melanie
    Batista, Nathalia Vieira
    Abe, Kento
    Rathod, Bhavisha
    Kitaygorodski, Julia
    Piguet, Vincent
    Chandran, Vinod
    Silverberg, Mark S.
    Gingras, Anne-Claude
    Watts, Tania
    GASTROENTEROLOGY, 2022, 162 (07) : S1006 - S1006
12345